Registry of Lobbyists
Monthly communication reports in the last 6 months: 0
View all monthly communication reports: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Budget, Health, Research and Development, Taxation and Finance
|
Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved Mutiple Sclerosis (MS) disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.
|
Policies or Program
|
|
Budget, Health, Research and Development, Taxation and Finance
|
Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities.
|
Legislative Proposal, Bill or Resolution
|
|
Budget, Employment and Training, Health, Taxation and Finance
|
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty.
|
Regulation
|
|
Budget, Health, Housing, Taxation and Finance
|
Canada Health Act and regulations, as it relates to long-term and home care.
|
Regulation
|
|
Budget, Health, Taxation and Finance
|
Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including MS care.
|
Policies or Program
|
|
Budget, Employment and Training, Health, Pensions, Taxation and Finance
|
Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities.
|
Policies or Program
|
|
Budget, Health, Research and Development, Science and Technology, Taxation and Finance
|
Canadian Institutes of Health Research (CIHR) as it relates to federal funding & long term investment in health research.
|
Policies or Program
|
|
Budget, Employment and Training, Health, Housing, Pensions, Taxation and Finance
|
Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities.
|
Policies or Program
|
|
Budget, Health, Taxation and Finance
|
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities.
|
Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
|
|
Budget, Employment and Training, Health, Taxation and Finance
|
Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities.
|
Regulation, Policies or Program
|
|
Budget, Health, Research and Development, Science and Technology
|
Establishment of national strategy for neurological conditions, with respect to persons with MS and other neurological conditions.
|
Policies or Program, Legislative Proposal, Bill or Resolution
|
|
Budget, Employment and Training, Health, Housing, Labour, Pensions, Research and Development, Science and Technology, Taxation and Finance, Transportation
|
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
|
Legislative Proposal, Bill or Resolution, Policies or Program
|
|
Budget, Health, Housing, Taxation and Finance
|
Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers.
|
Policies or Program
|
|
Budget, Taxation and Finance
|
Measures and funding for the charitable sector generally.
|
Policies or Program
|
|
Budget, Health, Housing, Taxation and Finance
|
National Housing Strategy with respect for persons with MS and other chronic conditions and disabilities.
|
Policies or Program
|
|
Budget, Health, Housing, Taxation and Finance
|
Safe Long-Term Care Act with respect to persons affected by MS.
|
Legislative Proposal, Bill or Resolution
|
|
Budget, Health, Research and Development, Science and Technology, Taxation and Finance
|
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
|
Policies or Program, Grant, Contribution or Other Financial Benefit
|
End date of the last completed financial year: 2024-12-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| BC Provincial Health Services Authority (PHSA) | $57,943.00 | Yes |
| Chaudière Appalaches - Autres | $2,000.00 | No |
| Dept of Health & Social Services, Quebec | $1,589,462.00 | Yes |
| Emploi-Québec | $59,014.00 | Yes |
| Government of Alberta - Alberta Gaming - Community Initiative Program (Friendly Visiting) | $173,290.00 | Yes |
| Lanaudière - Autres | $863.00 | Yes |
| Lanaudière - Subvention Nouveaux horizons pour les aînés | $24,863.00 | Yes |
| Mauricie - Autres | $950.00 | Yes |
| Programme d'accompagnement en loisirs, Gouvernement du Québec / Government of Quebec | $23,047.00 | Yes |
| Saguenay autres - Fonds de relance communautaire | $25,291.00 | Yes |
| Saguenay autres - Projet MCC | $4,000.00 | Yes |
| Saguenay - Service Québec | $2,889.00 | Yes |
| Soutien à l'action bénévole, Gouvernement du Québec / Government of Quebec | $1,700.00 | Yes |
Address:
Suite 500
250 Dundas Street West
Toronto, ON M5T 2Z5
Canada
Telephone number:
416-922-6065
Benjamin Davis, Vice-President, Government Relations; President, Atlantic Division
MS Canada is not a subsidiary of any other parent companies.
MS Canada is not a coalition.
The activities of MS Canada are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
MS Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Mary Anne Carter | No public offices held
Firm: Earnscliffe Strategy Group